PHARMACOLOGICAL NAD+ BOOSTING EXHIBITS THERAPEUTIC POTENTIAL BY PRESERVING MITOCHONDRIAL INTEGRITY FROM PARKINSON’S- AND ALZHEIMER’S-RELATED NEURODEGENERATION
Noel Calingasan,
Jayandra Chiluwal,
Anatoly Starkov,
Gary Gibson,
Carlos Villalobos,
Lucia Núñez,
Victor Tapias
Affiliations
Noel Calingasan
Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America
Jayandra Chiluwal
Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America
Anatoly Starkov
Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; Robert Wood Johnson Medical School. Rutgers University, Pediatrics, New Jersey, United States of America
Gary Gibson
Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; Weill Cornell Medicine, Burke Neurological Institute, White Plains, United States of America
Carlos Villalobos
CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain
Lucia Núñez
CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain; University of Valladolid Medical School, Dept. Biochemistry And Molecular Biology And Physiology, Valladolid, Spain
Victor Tapias
Weill Cornell Medicine, Feil Family Brain And Mind Research Institute, New York, United States of America; CSIC - University of Valladolid, Institute Of Genetics And Molecular Biology, Valladolid, Spain; University of Valladolid Medical School, Dept. Biochemistry And Molecular Biology And Physiology, Valladolid, Spain